No Data
Innotek (688253.SH): plans to buy back shares for an amount between 50 million yuan and 0.1 billion yuan.
Innotek (688253.SH) announced that it plans to repurchase shares with an amount not less than CNY 50 million and not more than CNY 0.1 billion. The repurchase price of shares will not exceed CNY 50.00 per share. The shares repurchased this time will be used for the company's stock-based incentives and/or employee stock ownership plans at an appropriate time in the future, and will be transferred within 3 years after the announcement of the results of the share repurchase and share changes; if the company fails to transfer all repurchased shares within 3 years after the announcement of the results of the share repurchase and share changes, the unreleased repurchased shares will be cancelled. If the country makes adjustments to relevant policies, the repurchase will be subject to adjustment.
Innotek (688253.SH) has great confidence in the continuous development of its future business.
On July 30th, Gelonhui reported that Innotek (688253.SH) disclosed its investor relations activity records, which showed that the company will continue to expand the hospital coverage at the company level while continuing to work on admissions, further academic promotion and increasing product penetration. The company will also continue to introduce new products, and increase development in overseas and self-testing markets. The company has great confidence in the continuous development of its business in the future.
Innotek (688253.SH): Proposed buyback of shares worth 50 million to 0.1 billion yuan by the actual controller.
Innotek (688253.SH) announced on July 24th that Mr. Ye Fengguang and Ms. Zhang Xiujie, the company's actual controllers, proposed that the company repurchase its shares through the Shanghai Stock Exchange trading system using its own funds in a centralized bidding manner, based on their confidence in the company's future development and recognition of the company's value. The funds used for the repurchase of shares, which will be used for employee shareholding plan and/or equity incentive plan at a suitable future time, will not be less than RMB 50 million (inclusive) and not more than RMB 100 million (inclusive).
Innovita Biological Technology (SHSE:688253) Could Be Struggling To Allocate Capital
1.5349 million restricted shares of Innotek (688253.SH) will be listed for circulation on July 29th.
Innotek (688253.SH) announced that the total number of restricted shares of the company's IPO circulation this time is 1.5349 million shares, ...
Voluntary disclosure announcement regarding the performance forecast for the first half of 2024.
Innovita Biological Technology Co., Ltd.'s (SHSE:688253) Stock Is Soaring But Financials Seem Inconsistent: Will The Uptrend Continue?No Data
